The generalisability of randomised clinical trials: an interim external validity analysis of the ongoing SENOMAC trial in sentinel lymph node-positive breast cancer

PURPOSE: None of the key randomised trials on the omission of axillary lymph node dissection (ALND) in sentinel lymph-positive breast cancer have reported external validity, even though results indicate selection bias. Our aim was to assess the external validity of the ongoing randomised SENOMAC tri...

Descripción completa

Detalles Bibliográficos
Autores principales: de Boniface, Jana, Ahlgren, Johan, Andersson, Yvette, Bergkvist, Leif, Frisell, Jan, Lundstedt, Dan, Olofsson Bagge, Roger, Rydén, Lisa, Sund, Malin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031168/
https://www.ncbi.nlm.nih.gov/pubmed/31989379
http://dx.doi.org/10.1007/s10549-020-05537-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031168/
https://www.ncbi.nlm.nih.gov/pubmed/31989379
http://dx.doi.org/10.1007/s10549-020-05537-1

Ejemplares similares